These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7725641)

  • 41. Serological analysis of human IgG and IgE anti-insulin antibodies by solid-phase radioimmunoassays.
    Hamilton RG; Rendell M; Adkinson NF
    J Lab Clin Med; 1980 Dec; 96(6):1022-36. PubMed ID: 7000933
    [No Abstract]   [Full Text] [Related]  

  • 42. Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus.
    Kilpatrick JM; Virella G
    Clin Exp Immunol; 1980 Jun; 40(3):445-52. PubMed ID: 6998615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of anti-insulin activity by means of the complement fixation test.
    Kosmala U; Czarnowska J
    Pol Med J; 1967; 6(2):319-23. PubMed ID: 6030640
    [No Abstract]   [Full Text] [Related]  

  • 44. [Leukocyte migration inhibition and antibody levels in diabetes mellitus].
    Rózsás Z; Horváth M; Karádi I; Bretán M
    Orv Hetil; 1981 Aug; 122(35):2157-9. PubMed ID: 7301376
    [No Abstract]   [Full Text] [Related]  

  • 45. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
    Franke B; Galloway TS; Wilkin TJ
    Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From sand rats to diabetic patients: is non-insulin-dependent diabetes mellitus a disease of the beta cell?
    Cerasi E; Kaiser N; Gross DJ
    Diabetes Metab; 1997 Mar; 23 Suppl 2():47-51. PubMed ID: 9105783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin resistance in malnutrition-related diabetes mellitus is not mediated by insulin antibodies.
    Rao RH
    Diabetes Care; 1992 May; 15(5):721-3. PubMed ID: 1516495
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Innate immunity, insulin resistance and type 2 diabetes.
    Fernández-Real JM; Pickup JC
    Trends Endocrinol Metab; 2008 Jan; 19(1):10-6. PubMed ID: 18082417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Insulin-binding capacity of the serum in diabetic patients with increased insulin need].
    Kühnau J
    Verh Dtsch Ges Inn Med; 1968; 74():1133-5. PubMed ID: 5714252
    [No Abstract]   [Full Text] [Related]  

  • 52. A case of diabetic coma with anti-insulin antibodies.
    Kato N; Uzawa H; Hayashi T; Onoue K
    Kumamoto Med J; 1977 Mar; 30(1):32-9. PubMed ID: 611314
    [No Abstract]   [Full Text] [Related]  

  • 53. [Anti-insulin antibodies and their development in relation to therapy].
    Synek M
    Cesk Pediatr; 1987 Oct; 42(10):614-6. PubMed ID: 3322582
    [No Abstract]   [Full Text] [Related]  

  • 54. [Immunoreactive insulin and insulin sensitivity in children and adolescents with diabetes mellitus complicated by lipodystrophy].
    Kniaziev IuA; Bielousova LV; Domanova VT
    Pediatr Akus Ginekol; 1980; (3):22-4. PubMed ID: 6995917
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antireceptor antibodies and insulin resistance. The B type syndrome].
    Lauro R; De Pirro R
    Recenti Prog Med; 1980 Feb; 68(2):189-99. PubMed ID: 6988907
    [No Abstract]   [Full Text] [Related]  

  • 56. Impaired metabolic response to regular insulin in the presence of a high level of circulating insulin-binding immunoglobulin G.
    Chantelau E; Sonnenberg GE; Heding LG; Berger M
    Diabetes Care; 1984; 7(4):403-4. PubMed ID: 6468239
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the pathogenesis of insulin resistance caused by antibodies].
    Kasemir H; Kerp L; Kieling F
    Verh Dtsch Ges Inn Med; 1968; 74():555-8. PubMed ID: 5714380
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the treatment of chronic resistance to insulin. Insulin antibodies in patients who are treated with intravenous insulin].
    Bemm H; Kluge HO; Lohmann D; Rotzsch W; Schäfer A
    Munch Med Wochenschr; 1968 Nov; 110(47):2780-6. PubMed ID: 5755294
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunological resistance to human biosynthetic insulin--effects of immunosuppression and plasmapheresis.
    Micić D; Brkić S; Kendereski A; Popović V; Zorić S; Nikolić JA; Igrutinović L; Ivanoska D; Manojlović D; Micić J
    Diabetes Res Clin Pract; 1993 Jan; 19(1):83-9. PubMed ID: 8472623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assay of circulating anti-insulin antibodies by radioimmunoprecipitation].
    Cotisson A; Hartmann DJ; Ville G
    Ann Biol Clin (Paris); 1984; 42(5):375-9. PubMed ID: 6507959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.